Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema (left eye)
ICD-10 E09.3292 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema (left eye).
E09.3292 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by mild nonproliferative diabetic retinopathy in the left eye without macular edema. This condition arises when certain medications or substances disrupt normal glucose metabolism, leading to hyperglycemia and subsequent diabetic complications. Nonproliferative diabetic retinopathy is an early stage of diabetic eye disease where small blood vessels in the retina become damaged, but there is no significant swelling or leakage of fluid into the macula. Management of this condition often involves monitoring blood glucose levels, maintaining HbA1c levels below 7%, and addressing any ocular complications. Insulin therapy may be necessary depending on the severity of the diabetes and the patient's response to other treatments. Regular eye examinations are crucial for early detection and management of retinopathy.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes due to medication, requiring insulin therapy.
Ensure accurate documentation of the drug responsible for diabetes and its management.
Comprehensive eye exam findings, including retinal imaging and assessment of retinopathy.
Patients with diabetes presenting for routine eye exams or with visual complaints.
Document the specific type and severity of retinopathy and any treatment provided.
Used during routine eye exams for diabetic patients.
Document visual acuity, retinal findings, and any treatment plans.
Ophthalmologists should ensure detailed documentation of retinopathy findings.
Common medications that can induce diabetes include corticosteroids, certain antipsychotics, and some diuretics. It is important to review the patient's medication history to identify potential causes.
Diabetic retinopathy is diagnosed through a comprehensive eye examination, including retinal imaging and assessment of visual acuity. Early detection is crucial for effective management.
